Seer, Inc. is a life sciences company. It is developing products that open a new gateway to the proteome. Its Proteograph product suite is an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation and software to perform proteomic analysis at scale in a matter of hours. The Proteograph has detected over 36,000 proteins across multiple species, and its performance and capabilities have been demonstrated in over 33 peer-reviewed publications, preprints and reviews. The Proteograph Product Suite is detector-agnostic and is adaptable to other protein detection instruments. The MS component of the Proteograph workflow is either provided by the researcher’s laboratory, can be outsourced to a third-party provider, or be run through the Seer Technology Access Center (STAC), which is its in-house service program. It has launched Proteograph XT, which enhances the sample throughput of the Proteograph Product Suite and MS instrument.
Mã chứng khoánSEER
Tên công tySeer Inc
Ngày IPODec 04, 2020
Giám đốc điều hànhFarokhzad (Omid C)
Số lượng nhân viên134
Loại chứng khoánOrdinary Share
Kết thúc năm tài chínhDec 04
Địa chỉ3800 Bridge Parkway, Suite 102
Thành phốREDWOOD CITY
Sàn giao dịch chứng khoánNASDAQ OMX - NASDAQ BASIC
Quốc giaUnited States of America
Mã bưu điện94065
Điện thoại16504530000
Trang webhttps://seer.bio/
Mã chứng khoánSEER
Ngày IPODec 04, 2020
Giám đốc điều hànhFarokhzad (Omid C)
Tổng cộng
0.00
USD đã được phân phối dưới dạng cổ tức trong 5 năm qua.

Không có dữ liệu